Jin Medical International
ZJYL
4 hedge funds and large institutions have $35.4K invested in Jin Medical International in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
306% more capital invested
Capital invested by funds: $8.73K → $35.4K (+$26.7K)
100% more funds holding
Funds holding: 2 → 4 (+2)
0.25% more ownership
Funds ownership: 0% → 0.25% (+0.25%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$36K |
| 2 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$579 |
ZJYL Hedge Fund Activity: Q2 2026 in Review
4 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q2 2026, worth a combined $35.4K — up 306% from $8.73K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ZJYL positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $36K. The largest seller was UBS Group, cutting an estimated $579.
- 4 institutional investors held Jin Medical International (ZJYL) as of Q2 2026, up from 2 in Q1 2026.
- Funds reported $35.4K of Jin Medical International stock for Q2 2026, up 306% quarter-over-quarter.
- 2 funds opened new Jin Medical International positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest Jin Medical International buyer in Q2 2026 was HRT Financial, an estimated $36K added.
- The largest Jin Medical International seller in Q2 2026 was UBS Group, an estimated $579 sold.
Based on aggregated 13F filings for Q2 2026.